Overview

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
Bioequivalence Study of GP40141 (GEROPHARM) versus Enplate®. The study of comparative pharmacodynamics, pharmacokinetics and safety of drugs containing romiplostim in healthy volunteers after a single subcutaneous injection.
Phase:
Phase 1
Details
Lead Sponsor:
Geropharm